Product Program year 2025 Source: CMS Open Payments

Pulsar-18 T3

Device Cardiology/Vascular Diseases

PDI 07640130446953

Open in the dashboard

General payments

$56,794

1,246 payments

Research payments

$0

0 payments

Through program year 2025, $56,794 in general payments and $0 in research payments were reported against Pulsar-18 T3 (Cardiology/Vascular Diseases).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2025 General $3,536 105
2024 General $8,449 244
2023 General $7,475 271
2022 General $37,335 626

Breakdown

Who paid General payments · program years 2022–2025
  1. Biotronik Inc. $56,794 1,246 payments
Top recipients General payments · program year 2025
  1. Gregory Messner Thoracic Surgery (Cardiothoracic Vascular Surgery) · Plano, TX $323 9% · 10 payments
  2. William English Vascular Surgery · San Antonio, TX $244 7% · 9 payments
  3. Senthil Palaniappun Vascular & Interventional Radiology · Oklahoma City, OK $191 5% · 3 payments
  4. Demetrios MacRis Vascular Surgery · San Antonio, TX $189 5% · 8 payments
  5. Nikhil Joshi Interventional Cardiology · Sherman, TX $167 5% · 7 payments

The top 5 of 47 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Vascular Surgery Surgery $955 27% · 14 practitioners
  2. Thoracic Surgery (Cardiothoracic Vascular Surgery) $598 17% · 4 practitioners
  3. Cardiovascular Disease Internal Medicine $534 15% · 8 practitioners
  4. Interventional Cardiology Internal Medicine $425 12% · 5 practitioners
  5. Vascular & Interventional Radiology Radiology $422 12% · 5 practitioners

The top 5 of 10 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Texas $2,370 67% · 28 recipients
  2. Florida $354 10% · 3 recipients
  3. California $293 8% · 4 recipients
  4. Louisiana $130 4% · 1 recipient
  5. New York $128 4% · 2 recipients

The top 5 of 9 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

1,246 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record